ABSTRACT
Sleep disturbances and depression are closely linked and share a bidirectional relationship. These interconnections can inform the pathophysiology underlying each condition. Insomnia is an established and modifiable risk factor for depression, the treatment of which offers the critical opportunity to prevent major depressive episodes, a paradigm-shifting model for psychiatry. Identification of occult sleep disorders may also improve outcomes in treatment-resistant depression. Sleep alterations and manipulations may additionally clarify the mechanisms that underlie rapid-acting antidepressant therapies. Both sleep disturbance and depression are heterogeneous processes, and evolving standards in psychiatric research that consider the transdiagnostic components of each are more likely to lead to translational progress at their nexus. Emerging tools to objectively quantify sleep and its disturbances in the home environment offer great potential to advance clinical care and research, but nascent technologies require further advances and validation prior to widespread application at the interface of sleep and depression.
Subject(s)
Depression , Sleep Disorders, Intrinsic , Depression/physiopathology , Depression/therapy , Humans , Patient Care Management/methods , Patient Care Management/trends , Psychopathology/methods , Sleep/physiology , Sleep Disorders, Intrinsic/psychology , Sleep Disorders, Intrinsic/therapySubject(s)
Depression , Schizophrenia , Sleep Disorders, Intrinsic , Biomarkers/blood , Depression/blood , Depression/physiopathology , Depression/therapy , Humans , Metabolic Diseases/psychology , Patient Care Management/methods , Patient Care Management/trends , Risk Factors , Schizophrenia/blood , Schizophrenia/physiopathology , Schizophrenia/therapy , Sleep/physiology , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/psychology , Sleep Disorders, Intrinsic/therapyABSTRACT
There are no standardized management algorithms for neonates with Pierre Robin sequence. Currently available literature is variable in terms of outcomes assessed across studies. In this paper, we have aimed to summarize the currently available literature on longitudinal sleep and respiratory outcomes in Pierre Robin sequence neonates with a focus on identifying gaps in literature and areas for future research development.
Subject(s)
Pierre Robin Syndrome/diagnosis , Pierre Robin Syndrome/therapy , Respiratory Distress Syndrome, Newborn/diagnosis , Sleep Disorders, Intrinsic/diagnosis , Child, Preschool , Follow-Up Studies , Humans , Infant , Infant, Newborn , Longitudinal Studies , Mandibular Osteotomy , Polysomnography , Respiratory Distress Syndrome, Newborn/therapy , Sleep Apnea, Obstructive/diagnosis , Sleep Apnea, Obstructive/therapy , Sleep Disorders, Intrinsic/therapy , Tracheostomy , Treatment OutcomeABSTRACT
STUDY OBJECTIVES: Sleep is important for memory consolidation in children. This study intended to find out whether an evening milk-based drink could influence sleep efficiency and memory recall in a group of Indonesian children (5-6 years old) with sleep deprivation. METHODS: Children were randomly allocated to one of three interventions: Reference product, satiety-stimulating product, and a relaxing product. The intervention lasted for 6 weeks and children consumed two servings per day of each 200â ml, the serving in the morning being the same for all children. All measurements took place at baseline and at the end of the intervention. Sleep parameters were studied using actigraphy and a sleep diary during three consecutive days. Memory consolidation was tested using a 20 word-pair list, which was memorized the evening before being recalled the next morning at home-base. Anthropometry was measured using standard equipment. RESULTS: The Satiety group showed a significant decrease in word recall, and a significant increase in nocturnal awakenings that was inversely associated with sleep efficiency at the end of the intervention. Sleep efficiency did not differ between the three groups being 75.5 ± 8.6% and 75.7 ± 6.3% at baseline and end of the intervention, respectively. Despite the lower energy intake in the Standard (reference) group, this condition showed the highest increase in weight. DISCUSSION: Evening growing-up milks can affect memory recall, sleep characteristics, and growth. However, to correct sleep efficiency and sleep duration, improvement of parental behavior may be the most important factor with nutrition providing a supplementary effect.
Subject(s)
Child Nutritional Physiological Phenomena , Dietary Supplements , Hypnotics and Sedatives/therapeutic use , Milk , Sleep Disorders, Intrinsic/therapy , Actigraphy , Animals , Appetite Depressants/administration & dosage , Appetite Depressants/adverse effects , Child , Child, Preschool , Dietary Supplements/adverse effects , Double-Blind Method , Female , Humans , Hypnotics and Sedatives/administration & dosage , Hypnotics and Sedatives/adverse effects , Indonesia , Male , Memory Consolidation , Memory Disorders/etiology , Memory Disorders/prevention & control , Mental Recall , Milk/adverse effects , Severity of Illness Index , Sleep Deprivation/etiology , Sleep Deprivation/prevention & control , Sleep Disorders, Intrinsic/physiopathology , Snacks , Weight GainABSTRACT
INTRODUCTION: Attention deficit hyperactivity disorder (ADHD) affects approximately 5% of all children and adolescents, and these patients frequently suffer from sleep problems. The association between sleep disorders and ADHD, however, is multifaceted and complex. AIMS: To explore the relationship between sleep disorders and ADHD. DEVELOPMENT: Sleep problems in children with ADHD include altered sleep and specific disorders per se or that may be due to comorbid psychiatric disorders or to the stimulants they receive as treatment for their ADHD. Today, an evaluation of the sleep conditions in children with ADHD is recommended before starting pharmacological treatment. The first step in managing their sleep problems is good sleep hygiene and cognitive-behavioural psychotherapy. Another option is to consider modifying the dosage and formulation of the stimulants. Atomoxetine and melatonin are therapeutic alternatives for children with ADHD and more severe sleep problems. Specific treatments exist for respiratory and movement disorders during sleep. CONCLUSIONS: It is important to evaluate sleep in children who present symptoms suggestive of ADHD, since problems during sleep can play a causal role or exacerbate the clinical features of ADHD. Correct evaluation and treatment of sleep disorders increase the family's and the child's quality of life and can lessen the severity of the symptoms of ADHD.
TITLE: Evaluacion y tratamiento de los problemas de sueño en niños diagnosticados de trastorno por deficit de atencion/hiperactividad: actualizacion de la evidencia.Introduccion. El trastorno por deficit de atencion/hiperactividad (TDAH) afecta aproximadamente al 5% de los niños y adolescentes, y los problemas del sueño son comunes en estos pacientes. Sin embargo, la asociacion entre los trastornos del sueño y el TDAH es multifacetica y compleja. Objetivo. Explorar la relacion entre los trastornos del sueño y el TDAH. Desarrollo. Los problemas del sueño en niños con TDAH incluyen alteraciones del sueño y trastornos especificos per se o debidos a trastornos psiquiatricos comorbidos o a los farmacos estimulantes para el TDAH. Actualmente se recomienda la evaluacion de las condiciones del sueño en niños con TDAH antes de la iniciacion del tratamiento farmacologico. La primera linea de actuacion para el manejo de los problemas de sueño es la higiene del sueño y la psicoterapia cognitivo-conductual. Otra opcion es considerar la modificacion de la posologia y formulacion de los farmacos estimulantes. La atomoxetina y la melatonina son alternativas terapeuticas para los niños con TDAH y problemas del sueño mas graves. Para los trastornos respiratorios y del movimiento en el sueño existen tratamientos especificos. Conclusiones. Es importante evaluar el sueño en los niños que presentan sintomas sugestivos de TDAH, ya que los problemas en el sueño pueden desempeñar un papel causal o exacerbar la clinica del TDAH. Una correcta evaluacion y tratamiento de los trastornos del sueño aumentan la calidad de vida de la familia y del niño y pueden disminuir la gravedad de los sintomas del TDAH.
Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Sleep Disorders, Intrinsic/epidemiology , Actigraphy , Attention Deficit Disorder with Hyperactivity/drug therapy , Causality , Central Nervous System Stimulants/adverse effects , Central Nervous System Stimulants/therapeutic use , Child , Child Behavior Disorders/epidemiology , Chronobiology Disorders/epidemiology , Comorbidity , Humans , Medical Records , Mental Disorders/epidemiology , Polysomnography , Prevalence , Restless Legs Syndrome/epidemiology , Sleep Apnea Syndromes/epidemiology , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/therapy , Sleep LatencyABSTRACT
OBJECTIVE: To determine if the non-motor sections of the Movement Disorder Society's (MDS) version of the Unified Parkinson's Disease Rating Scale (UPDRS) could supplement the original UPDRS as a patient completed assessment of changes in non-motor symptoms in Parkinson's disease (PD) patients after bilateral subthalamic nucleus (STN) deep brain stimulation (DBS). METHODS: Thirty PD patients who underwent bilateral STN DBS were assessed using the total UPDRS and the non-motor sections of the MDS-UPDRS prior to surgery and one year following surgery. This study focuses on non-motor symptoms as assessed by Part I of the UPDRS and Part 1A and 1B of the MDS-UPDRS. RESULTS: One year following surgery, no individual non-motor symptoms or the total mentation score of the UPDRS were significantly changed. In comparison, the MDS-UPDRS showed significant improvements in sleep and urinary problems and a trend towards improvement in anxiety, constipation, daytime sleepiness, fatigue and pain. CONCLUSIONS: This study provides evidence that the MDS-UPDRS non-motor sections, when completed by the patients, can supplement the original version of the UPDRS as an effective method of measuring changes in non-motor symptoms after DBS. It also reinforces the benefits of bilateral STN DBS on non-motor symptoms of PD.
Subject(s)
Deep Brain Stimulation , Parkinson Disease/therapy , Severity of Illness Index , Subthalamic Nucleus , Symptom Assessment/methods , Aged , Anxiety/etiology , Anxiety/therapy , Cognition Disorders/etiology , Cognition Disorders/therapy , Constipation/etiology , Constipation/therapy , Fatigue/etiology , Fatigue/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pain/etiology , Parkinson Disease/complications , Parkinson Disease/physiopathology , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/therapy , Subthalamic Nucleus/physiopathology , Treatment OutcomeABSTRACT
Sleep deteriorates with age. The menopause is often a turning point for women's sleep, as complaints of insomnia increase significantly thereafter. Insomnia can occur as a secondary disorder to hot flashes, mood disorders, medical conditions, psychosocial factors, underlying intrinsic sleep disorders, such as obstructive sleep apnoea (OSA) or restless legs syndrome (RLS), or it can be a primary disorder. Since unrecognized OSA can have dramatic health-related consequences, menopausal women complaining of persisting sleep disturbances suggesting primary insomnia or intrinsic sleep disorders should be referred to a sleep specialist for a comprehensive sleep assessment. Patients suffering from primary insomnia will be preferentially treated with non-benzodiazepine hypnotics or melatonin, or with cognitive behavioural therapy. Insomnia related to vasomotor symptoms can be improved with hormone replacement therapy. Gabapentin and isoflavones have also shown efficacy in small series but their precise role has yet to be established. In patients suffering from OSA, non-pharmacological therapy will be applied: continuous positive airway pressure or an oral appliance, according to the severity of the disorder. In the case of RLS, triggering factors must be avoided; dopaminergic agonists are the first-line treatment for moderate to severe disease. In conclusion, persisting sleep complaints should be addressed in menopausal women, in order to correctly diagnose the specific causal disorder and to prescribe treatments that have been shown to improve sleep quality, quality of life and long-term health status.
Subject(s)
Menopause , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/therapy , Female , Hot Flashes/drug therapy , Humans , Restless Legs Syndrome/drug therapy , Sleep , Sleep Apnea, Obstructive/therapy , Sleep Initiation and Maintenance Disorders/therapyABSTRACT
This is a review of the different complementary techniques that are useful for optimizing home mechanical ventilation (HMV). Airway clearance is very important in patients with HMV and many patients, particularly those with reduced peak cough flow, require airway clearance (manual or assisted) or assisted cough techniques (manual or mechanical) and suctioning procedures, in addition to ventilation. In the case of invasive HMV, good tracheostomy cannula management is essential for success. HMV patients may have sleep disturbances that must be taken into account. Sleep studies including complete polysomnography or respiratory polygraphy are helpful for identifying patient-ventilator asynchrony. Other techniques, such as bronchoscopy or nutritional support, may be required in patients on HMV, particularly if percutaneous gastrostomy is required. Information on treatment efficacy can be obtained from HMV monitoring, using methods such as pulse oximetry, capnography or the internal programs of the ventilators themselves. Finally, the importance of the patient's subjective perception is reviewed, as this may potentially affect the success of the HMV.
Subject(s)
Complementary Therapies/methods , Home Care Services , Respiration, Artificial/methods , Airway Obstruction/prevention & control , Complementary Therapies/psychology , Cough , Diagnostic Techniques, Respiratory System/instrumentation , Forecasting , Humans , Kyphosis/complications , Nutritional Support , Obesity Hypoventilation Syndrome/therapy , Patients/psychology , Positive-Pressure Respiration , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/therapy , Quality of Life , Respiration, Artificial/psychology , Scoliosis/complications , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/therapy , Suction , Tracheostomy/instrumentation , Tracheostomy/methods , Ventilators, MechanicalABSTRACT
Traumatic brain injury (TBI) is a major health concern in industrialised countries. Sleep and wake disturbances are among the most persistent and disabling sequelae after TBI. Yet, despite the widespread complaints of post-TBI sleep and wake disturbances, studies on their etiology, pathophysiology, and treatments remain inconclusive. This narrative review aims to summarise the current state of knowledge regarding the nature of sleep and wake disturbances following TBI, both subjective and objective, spanning all levels of severity and phases post-injury. A second goal is to outline the various causes of post-TBI sleep-wake disturbances. Globally, although sleep-wake complaints are reported in all studies and across all levels of severity, consensus regarding the objective nature of these disturbances is not unanimous and varies widely across studies. In order to optimise recovery in TBI survivors, further studies are required to shed light on the complexity and heterogeneity of post-TBI sleep and wake disturbances, and to fully grasp the best timing and approach for intervention.
Subject(s)
Brain Injuries/complications , Chronobiology Disorders/etiology , Sleep Disorders, Intrinsic/etiology , Blast Injuries/complications , Blast Injuries/physiopathology , Brain Damage, Chronic/etiology , Brain Damage, Chronic/physiopathology , Brain Injuries/physiopathology , Chronobiology Disorders/physiopathology , Cognitive Behavioral Therapy , Disorders of Excessive Somnolence/etiology , Disorders of Excessive Somnolence/physiopathology , Endocrine System Diseases/etiology , Endocrine System Diseases/physiopathology , Hospitalization , Humans , Hypnotics and Sedatives/therapeutic use , Inpatients/psychology , Melatonin/therapeutic use , Military Personnel , Sleep Disorders, Intrinsic/physiopathology , Sleep Disorders, Intrinsic/rehabilitation , Sleep Disorders, Intrinsic/therapy , Warfare , Wounds, Nonpenetrating/complications , Wounds, Nonpenetrating/physiopathologyABSTRACT
BACKGROUND: Poor sleep is prevalent in patients with systemic inflammatory disorders, including rheumatoid arthritis, and, in addition to fatigue, pain, depression and inflammation, is associated with an increased risk of co-morbidity and all-cause mortality. Whereas non-pharmacological interventions in patients with rheumatoid arthritis have been shown to reduce pain and fatigue, no randomized controlled trials have examined the effect of non-pharmacological interventions on improvement of sleep in patients with rheumatoid arthritis. The aim of this trial was to evaluate the efficacy of an intermittent aerobic exercise intervention on sleep, assessed both objectively and subjectively in patients with rheumatoid arthritis. METHODS/DESIGN: A randomized controlled trial including 44 patients with rheumatoid arthritis randomly assigned to an exercise training intervention or to a control group. The intervention consists of 18 session intermittent aerobic exercise training on a bicycle ergometer three times a week. Patients are evaluated according to objective changes in sleep as measured by polysomnography (primary outcome). Secondary outcomes include changes in subjective sleep quality and sleep disturbances, fatigue, pain, depressive symptoms, physical function, health-related quality of life and cardiorespiratory fitness. DISCUSSION: This trial will provide evidence of the effect of intermittent aerobic exercise on the improvement of sleep in patients with rheumatoid arthritis, which is considered important in promotion of health and well-being. As such, the trial meets a currently unmet need for the provision of non-pharmacological treatment initiatives of poor sleep in patients with rheumatoid arthritis. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01966835.
Subject(s)
Arthritis, Rheumatoid/therapy , Exercise , Sleep Disorders, Intrinsic/therapy , Adolescent , Adult , Aged , Arthritis, Rheumatoid/complications , Fatigue/etiology , Female , Humans , Male , Middle Aged , Patient Selection , Polysomnography , Single-Blind Method , Sleep Disorders, Intrinsic/etiology , Young AdultABSTRACT
Pediatric insomnia is an extrinsic sleep disorder subdivided into two categories: behavioral insomnia and insomnia related to medical, neurological, and psychiatric diseases. This review will cover several types of insomnia, comorbidities and specific pediatric therapies according to clinical characteristics and age. Behavioral insomnia should be differentiated from pediatric insomnia due to medical conditions, mostly occurring during the first year of life. Multiple night awakenings and diurnal hypersomnolence are strong indicators of insomnia due to medical conditions. Insomnia during adolescence and pediatric insomnia associated with psychiatric comorbidity, cognitive disabilities and epilepsy, will be discussed in terms of diagnosis, clinical features and implications for treatment.
TITLE: Insomnio pediatrico: clinica, diagnostico y tratamiento.El insomnio pediatrico es un trastorno de sueño extrinseco que puede subdividirse en dos categorias: insomnio conductual e insomnio relacionado con trastornos medicos, neurologicos y psiquiatricos. En esta revision presentamos varios tipos de insomnios, comorbilidad y terapias especificas de acuerdo con la edad y con las caracteristicas clinicas. El insomnio conductual se debe diferenciar del insomnio pediatrico por causas medicas, ya que este ultimo aparece, normalmente, en el primer año de vida. Los despertares nocturnos frecuentes y la somnolencia diurna excesiva indican un insomnio debido a causas medicas. El insomnio del adolescente y el insomnio pediatrico asociado a trastornos psiquiatricos, alteraciones cognitivas y epilepsia se discutiran en terminos de diagnostico, hallazgos clinicos e implicaciones terapeuticas.
Subject(s)
Sleep Initiation and Maintenance Disorders , Adolescent , Behavior Therapy , Child , Child Behavior Disorders/diagnosis , Child Behavior Disorders/therapy , Chronobiology Disorders/complications , Chronobiology Disorders/drug therapy , Chronobiology Disorders/therapy , Cognition Disorders/complications , Comorbidity , Diagnosis, Differential , Dyssomnias/therapy , Epilepsy/complications , Epilepsy/drug therapy , Food Hypersensitivity/complications , Gastroesophageal Reflux/complications , Humans , Hypnotics and Sedatives/therapeutic use , Melatonin/pharmacokinetics , Melatonin/therapeutic use , Mental Disorders/complications , Mental Disorders/diagnosis , Mental Disorders/drug therapy , Mental Disorders/therapy , Psychotropic Drugs/therapeutic use , Sleep Disorders, Intrinsic/diagnosis , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/physiopathology , Sleep Disorders, Intrinsic/therapy , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/etiology , Sleep Initiation and Maintenance Disorders/psychology , Sleep Initiation and Maintenance Disorders/therapy , Substance-Related Disorders/complicationsABSTRACT
Insufficient sleep is common in the general population, and can result from environmental and psychosocial factors, medical and psychiatric disorders, and sleep disorders, such as insomnia, circadian rhythm disorders, sleep apnoea and restless legs. Women are particularly at risk for sleep disorders, and complaints of sleep disturbance are more prevalent among women than men across the life span. During the perinatal period, many common sleep disorders, such as obstructive sleep apnoea or restless legs may be exacerbated, or in the case of insomnia or narcolepsy, treatment options may change. In addition, the role of circadian rhythms in fertility and perinatal health is just beginning to be appreciated. In this chapter, we provide an overview of the current knowledge of the unique aspects of diagnosis and treatment of sleep disorders during the perinatal period.
Subject(s)
Pregnancy Complications/etiology , Sleep Disorders, Circadian Rhythm/complications , Sleep Disorders, Intrinsic/complications , Sleep Disorders, Intrinsic/therapy , Continuous Positive Airway Pressure , Female , Humans , Narcolepsy/therapy , Peripartum Period , Pregnancy , Restless Legs Syndrome/drug therapy , Restless Legs Syndrome/etiology , Sleep Apnea, Obstructive/complications , Sleep Apnea, Obstructive/diagnosis , Sleep Apnea, Obstructive/therapy , Sleep Disorders, Intrinsic/diagnosis , Sleep Initiation and Maintenance Disorders/therapyABSTRACT
Multiple sclerosis continues to present a host of rehabilitation challenges, specifically the impact of secondary "hidden" conditions on quality of life, participation, and employment. To discuss the current state of rehabilitation research and direct future research endeavors, a state of the science conference was held in November 2010 in Alexandria, Virginia. The conference was presented by the University of Washington's Multiple Sclerosis Rehabilitation Research and Training Center and focused on the current state of research into secondary conditions, outcomes measurement, employment, and the utility of psychotherapeutic interventions. This article discusses the details and recommendations of this conference.
Subject(s)
Biomedical Research , Multiple Sclerosis/rehabilitation , Cognition Disorders/therapy , Depression/therapy , Employment , Fatigue/therapy , Humans , Multiple Sclerosis/complications , Pain Management , Patient Outcome Assessment , Quality of Life , Self Care , Sleep Disorders, Intrinsic/therapy , Surveys and QuestionnairesABSTRACT
The purpose of this pilot study was to evaluate the feasibility and effectiveness of a yoga program as an adjunctive therapy for improving post-traumatic stress disorder (PTSD) symptoms in Veterans with military-related PTSD. Veterans (n = 12) participated in a 6 week yoga intervention held twice a week. There was significant improvement in PTSD hyperarousal symptoms and overall sleep quality as well as daytime dysfunction related to sleep. There were no significant improvements in the total PTSD, anger, or quality of life outcome scores. These results suggest that this yoga program may be an effective adjunctive therapy for improving hyperarousal symptoms of PTSD including sleep quality. This study demonstrates that the yoga program is acceptable, feasible, and that there is good adherence in a Veteran population.
Subject(s)
Stress Disorders, Post-Traumatic/therapy , Veterans/psychology , Yoga/psychology , Anger , Arousal , Female , Humans , Male , Middle Aged , Patient Acceptance of Health Care , Pilot Projects , Quality of Life , Sleep Disorders, Intrinsic/etiology , Sleep Disorders, Intrinsic/therapy , Stress Disorders, Post-Traumatic/complications , United StatesABSTRACT
The significance for maternal and fetal health of gestational obstructive sleep apnea, primary insomnia, restless legs syndrome, and narcolepsy are summarized. The pathophysiology, signs, symptoms, and basic Sleep Medicine concepts that assist the obstetrician in suspecting these 4 conditions are described. Where appropriate, initial management options are also outlined. Referral guidelines to a Sleep Medicine specialist are included when further diagnostic, severity assessment, and management suggestions are needed.
Subject(s)
Pregnancy Complications , Sleep Disorders, Intrinsic , Female , Humans , Narcolepsy , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/therapy , Restless Legs Syndrome/physiopathology , Sleep Apnea, Obstructive , Sleep Disorders, Intrinsic/diagnosis , Sleep Disorders, Intrinsic/therapy , Sleep Initiation and Maintenance DisordersSubject(s)
Anemia, Sickle Cell/complications , Hemoglobins/analysis , Hypoxia/prevention & control , Oxygen Inhalation Therapy , Sleep Disorders, Intrinsic/therapy , Adult , Anemia, Sickle Cell/drug therapy , Antisickling Agents/therapeutic use , Erythropoiesis , Erythropoietin/blood , Female , Humans , Hydroxyurea/therapeutic use , Hypoxia/etiology , Male , Middle Aged , Oxygen Inhalation Therapy/methods , Pain/etiology , Pain/prevention & control , Reticulocyte Count , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
PURPOSE: After completing treatment, cancer survivors may suffer from a multitude of physical and mental health impairments, resulting in compromised quality of life. This exploratory study investigated whether two mind-body interventions, i.e., Mind-Body Bridging (MBB) and Mindfulness Meditation (MM), could improve posttreatment cancer survivors' self-reported sleep disturbance and comorbid symptoms, as compared to sleep hygiene education (SHE) as an active control. METHODS: This randomized controlled trial examined 57 cancer survivors with clinically significant self-reported sleep disturbance, randomly assigned to receive MBB, MM, or SHE. All interventions were conducted in three sessions, once per week. Patient-reported outcomes were assessed via the Medical Outcomes Study Sleep Scale and other indicators of psychosocial functioning relevant to quality of life, stress, depression, mindfulness, self-compassion, and well-being. RESULTS: Mixed effects model analysis revealed that mean sleep disturbance symptoms in the MBB (p = .0029) and MM (p = .0499) groups were lower than in the SHE group, indicating that both mind-body interventions improved sleep. In addition, compared with the SHE group, the MBB group showed reductions in self-reported depression symptoms (p = .040) and improvements in overall levels of mindfulness (p = .018), self-compassion (p = .028), and well-being (p = .019) at postintervention. CONCLUSIONS: This study provides preliminary evidence that brief sleep-focused MBB and MM are promising interventions for sleep disturbance in cancer survivors. Integrating MBB or MM into posttreatment supportive plans should enhance care of cancer survivors with sleep disturbance. Because MBB produced additional secondary benefits, MBB may serve as a promising multipurpose intervention for posttreatment cancer survivors suffering from sleep disturbance and other comorbid symptoms. IMPLICATIONS FOR CANCER SURVIVORS: Two brief sleep-focused mind-body interventions investigated in the study were effective in reducing sleep disturbance and one of them further improved other psychosocial aspects of the cancer survivors' life. Management of sleep problems in survivors is a high priority issue that demands more attention in cancer survivorship.
Subject(s)
Mind-Body Therapies , Neoplasms , Sleep Disorders, Intrinsic/therapy , Survivors , Adult , Aged , Attitude , Awareness , Depression/etiology , Emotions , Female , Humans , Male , Meditation , Middle Aged , Neoplasms/complications , Neoplasms/psychology , Patient Education as Topic , Pilot Projects , Prospective Studies , Quality of Life , Severity of Illness Index , Survivors/psychology , Treatment OutcomeABSTRACT
OBJECTIVES: Sleep disturbances can impair alertness and neurocognitive performance and increase the risk of falling asleep at the wheel. We investigated the prevalence of sleep disorders among public transport operators (PTOs) and assessed the interventional effects on hypersomnolence and neurocognitive function in those diagnosed with obstructive sleep apnea (OSA). METHODS: Overnight polygraphy and questionnaire data from 101 volunteers (72 males, median age 48 range [22-64] years, 87 PTOs) employed at the Gothenburg Public Transportation Company were assessed. Treatment was offered in cases with newly detected OSA. Daytime sleep episodes and neurocognitive function were assessed before and after intervention. RESULTS: At baseline, symptoms of daytime hypersomnolence, insomnia, restless legs syndrome as well as objectively assessed OSA (apnea hypopnea index (AHI, determined by polygraphic recording)=17[5-46]n/h) were highly present in 26, 24, 10 and 22%, respectively. A history of work related traffic accident was more prevalent in patients with OSA (59%) compared to those without (37%, p<0.08). In the intervention group (n=12) OSA treatment reduced AHI by -23 [-81 to -5]n/h (p=0.002), determined by polysomnography. Reduction of OSA was associated with a significant reduction of subjective sleepiness and blood pressure. Measures of daytime sleep propensity (microsleep episodes from 9 [0-20.5] to 0 [0-12.5], p<0.01) and missed responses during performance tests were greatly reduced, indices of sustained attention improved. CONCLUSIONS: PTOs had a high prevalence of sleep disorders, particularly OSA, which demonstrated a higher prevalence of work related accidents. Elimination of OSA led to significant subjective and objective improvements in daytime function. Our findings argue for greater awareness of sleep disorders and associated impacts on daytime function in public transport drivers.
Subject(s)
Accidents, Occupational , Accidents, Traffic , Sleep Disorders, Intrinsic , Accidents, Occupational/prevention & control , Accidents, Occupational/statistics & numerical data , Accidents, Traffic/prevention & control , Accidents, Traffic/statistics & numerical data , Adult , Attention , Cohort Studies , Female , Humans , Male , Middle Aged , Motor Vehicles , Polysomnography , Prevalence , Railroads , Severity of Illness Index , Sleep Apnea, Obstructive/diagnosis , Sleep Apnea, Obstructive/epidemiology , Sleep Apnea, Obstructive/physiopathology , Sleep Apnea, Obstructive/therapy , Sleep Disorders, Intrinsic/diagnosis , Sleep Disorders, Intrinsic/epidemiology , Sleep Disorders, Intrinsic/physiopathology , Sleep Disorders, Intrinsic/therapy , Surveys and Questionnaires , Sweden , Treatment Outcome , WakefulnessABSTRACT
PURPOSE/OBJECTIVES: To compare usual care with a home-based individualized exercise program (HBIEP) in patients receiving intensive treatment for multiple myeloma (MM)and epoetin alfa therapy. DESIGN: Randomized trial with repeated measures of two groups (one experimental and one control) and an approximate 15-week experimental period. SETTING: Outpatient setting of the Myeloma Institute for Research and Therapy at the Rockfellow Cancer Center at the University of Arkansas for Medical Sciences. SAMPLE: 187 patients with newly diagnosed MM enrolled in a separate study evaluating effectiveness of the Total Therapy regimen, with or without thalidomide. METHODS: Measurements included the Profile of Mood States fatigue scale, Functional Assessment of Cancer Therapy-Fatigue, ActiGraph® recordings, 6-Minute Walk Test, and hemoglobin levels at baseline and before and after stem cell collection. Descriptive statistics were used to compare demographics and treatment effects, and repeated measures analysis of variance was used to determine effects of HBIEP. MAIN RESEARCH VARIABLES: Fatigue, nighttime sleep, performance (aerobic capacity) as dependent or outcome measures, and HBIEP combining strength building and aerobic exercise as the independent variable. FINDINGS: Both groups were equivalent for age, gender, race, receipt of thalidomide, hemoglobin levels, and type of treatment regimen for MM. No statistically significant differences existed among the experimental and control groups for fatigue, sleep, or performance (aerobic capacity). Statistically significant differences (p < 0.05) were found in each of the study outcomes for all patients as treatment progressed and patients experienced more fatigue and poorer nighttime sleep and performance (aerobic capacity). CONCLUSIONS: The effect of exercise seemed to be minimal on decreasing fatigue, improving sleep, and improving performance (aerobic capacity). IMPLICATIONS FOR NURSING: Exercise is safe and has physiologic benefits for patients undergoing MM treatment; exercise combined with epoetin alfa helped alleviate anemia.